A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.

MLA

Bancroft, Elizabeth K., et al. “A Prospective Prostate Cancer Screening Programme for Men with Pathogenic Variants in Mismatch Repair Genes (IMPACT): Initial Results from an International Prospective Study.” The Lancet. Oncology, vol. 22, no. 11, Nov. 2021, pp. 1618–31. EBSCOhost, https://doi.org/10.1016/S1470-2045(21)00522-2.

APA

Bancroft, E. K., Page, E. C., Brook, M. N., Thomas, S., Taylor, N., Pope, J., McHugh, J., Jones, A.-B., Karlsson, Q., Merson, S., Ong, K. R., Hoffman, J., Huber, C., Maehle, L., Grindedal, E. M., Stormorken, A., Evans, D. G., Rothwell, J., Lalloo, F., … Eeles, R. A. (2021). A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study. The Lancet. Oncology, 22(11), 1618–1631. https://doi.org/10.1016/S1470-2045(21)00522-2

Chicago

Bancroft, Elizabeth K, Elizabeth C Page, Mark N Brook, Sarah Thomas, Natalie Taylor, Jennifer Pope, Jana McHugh, et al. 2021. “A Prospective Prostate Cancer Screening Programme for Men with Pathogenic Variants in Mismatch Repair Genes (IMPACT): Initial Results from an International Prospective Study.” The Lancet. Oncology 22 (11): 1618–31. doi:10.1016/S1470-2045(21)00522-2.